Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma-Reference-Cited by-同舟云学术

Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma

Published:2016-10-11 Issue:6 Volume:14 Page:811-824
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Wanjale Mrunal Vitthal¹,Kumar G. S. Vinod¹

Affiliation:

1. Chemical Biology, Nano Drug Delivery Systems, Bio-Innovation Center (BIC), Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2017.1242574

Reference98 articles.

1. Brain Tumors

2. A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms

3. Chemoresistance of glioblastoma cancer stem cells - much more complex than expected

4. Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species

5. NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective;Vaccines;2024-08-22

2. Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases;Molecular Pharmaceutics;2024-07-22

3. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

4. Tumor-Homing Peptides as Crucial Component of Magnetic-Based Delivery Systems: Recent Developments and Pharmacoeconomical Perspective;International Journal of Molecular Sciences;2024-06-05

5. Recent Advancements and Strategies for Overcoming the Blood–Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma;Polymers;2023-10-02